SPAIN: Puleva Biotech posts 34% rise in H1 net profit

Spanish health food firm Puleva Biotech, a unit of food company Ebro Puleva, has posted a 34% rise in first-half net profit. The company’s net profit rose to €932,000 (US$1.06m), while revenue rose 23% to €2.28m. Puleva Biotech said it was to launch a new product on the market in the coming weeks. The firm said tests of its CV-17 food additive showed that in small regular doses it "significantly reduced numerous risk factors connected to heart disease," and the product would go on sale soon, reported Reuters.

July 22, 2003

Spanish health food firm Puleva Biotech, a unit of food company Ebro Puleva, has posted a 34% rise in first-half net profit.

The company’s net profit rose to €932,000 (US$1.06m), while revenue rose 23% to €2.28m.

Puleva Biotech said it was to launch a new product on the market in the coming weeks. The firm said tests of its CV-17 food additive showed that in small regular doses it “significantly reduced numerous risk factors connected to heart disease,” and the product would go on sale soon, reported Reuters.